Sex-Related Differences in Oxidative, Platelet, and Vascular Function in Chronic Users of Heat-not-Burn vs. Traditional Combustion Cigarettes.
cardiovascular disease
heat-not-burn cigarette
modified risk product
sex
smoking
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
24 Jun 2022
24 Jun 2022
Historique:
received:
27
05
2022
revised:
16
06
2022
accepted:
22
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Smoking is still a major cardiovascular risk factor, despite many public awareness campaigns and dedicated interventions. Recently, modified risk products (MRP), e.g., heat-not-burn cigarettes (HNBCs), have been introduced as surrogates of traditional combustion cigarettes (TCCs). Although these products are promoted as healthier than TCCs, few studies have been conducted to assess it. This work is a sex-focused sub-study of a prospective observational study in which apparently healthy chronic TCC smokers were age-matched with regular HNBC users. Blood samples were collected for biochemical assays and blood pressure and flow-mediated dilation (FMD) were measured. Out of 60 subjects, 33 (55%) were women, and 27 (45%) men, with 11 (33%) vs. 9 (33%) non-smokers, respectively, 10 (30%) vs. 10 (37%) TCC smokers, and 12 (36%) vs. 8 (30%) HNBC smokers (p = 0.946). Bivariate and multivariable analyses showed no statistically significant between-sex differences in NO, H2O2, sCD40L, sNox2-dp, sP-selectin, platelet aggregation, cotinine or FMD, overall, in non-smokers, in TCC smokers, or in HNBC smokers (all p > 0.05). HNBCs appeared safer than TCCs when focusing on Nox2-dp (p = 0.026) and sP-selectin (p = 0.050) but had similar levels of the other measured markers. In conclusion, HNBCs have similar detrimental effects on women and men’s oxidative stress (H2O2: p = 0.49; sNox2-dp: p = 0.31) and platelet activation (sP-selectin: p = 0.33; platelet aggregation p = 0.87).
Identifiants
pubmed: 35883727
pii: antiox11071237
doi: 10.3390/antiox11071237
pmc: PMC9311916
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Sapienza University of Rome
ID : RM118164264ED867
Références
Chest. 2016 Sep;150(3):606-12
pubmed: 27108682
Psychol Health. 2017 Aug;32(8):1018-1036
pubmed: 28553727
Neurotoxicology. 2022 Mar;89:140-160
pubmed: 35150755
Tob Prev Cessat. 2021 Nov 22;7:69
pubmed: 34877438
Sci Rep. 2021 Jun 3;11(1):11808
pubmed: 34083663
Curr Atheroscler Rep. 2020 Feb 7;22(2):8
pubmed: 32034541
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):
pubmed: 28093398
Minerva Cardiol Angiol. 2021 Jun;69(3):231-240
pubmed: 33703858
Int J Mol Sci. 2019 Dec 31;21(1):
pubmed: 31906252
Am J Epidemiol. 2003 Jun 1;157(11):973-9
pubmed: 12777360
Nicotine Tob Res. 2019 Jan 1;21(1):111-118
pubmed: 29319815
J UOEH. 2017;39(3):201-207
pubmed: 28904270
Am J Cardiol. 2011 Nov 15;108(10):1382-6
pubmed: 21924390
Addiction. 2018 Nov;113(11):2099-2106
pubmed: 29920842
Eur Heart J. 2001 Feb;22(3):201-8
pubmed: 11161931
Nicotine Tob Res. 2019 Aug 19;21(9):1285-1288
pubmed: 30476301
Curr Emerg Hosp Med Rep. 2020;8(3):103-109
pubmed: 32837803
JAMA Intern Med. 2017 Jul 1;177(7):1050-1052
pubmed: 28531246
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):e131-2
pubmed: 16857955
Atherosclerosis. 2017 Jul;262:123-130
pubmed: 28549278
Thorax. 2021 Jun;76(6):618-620
pubmed: 34157671
Lancet. 2015 Mar 14;385(9972):1011-8
pubmed: 25784348
PLoS One. 2020 Jun 4;15(6):e0234015
pubmed: 32497122
Physiol Rep. 2018 Feb;6(3):
pubmed: 29417753
Nicotine Tob Res. 2021 Jun 8;23(7):1143-1152
pubmed: 33502518
Cochrane Database Syst Rev. 2021 Jan 4;1:CD013229
pubmed: 33411338
Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1234-H1239
pubmed: 33006919